Time to metastasis after prostatectomy should not be used as a prognostic factor for metachronou...

Combining chemotherapy with cemiplimab for advanced penile cancer may serve as a viable first-li...

KIM-1 is a good prognostic and predictive biomarker in advanced renal cell carcinoma

UGN-102 shows better results after 12 months of treatment for low-grade intermediate-risk NMIBC

177Lu-PSMA-617 with concomitant ARPIs shows is more efficacious than SoC in mCRPC

Mobile prostate cancer screening clinic can help address barriers to serving high-risk communities

CaboNivo shows sustained long-term benefits for survival and tumour progression as a 1L treatmen...

HSD3B1 inheritance reduces OS in high-risk nmPC patients on ADT enzalutamide, abiraterone acetat...

Enfortumab vedotin in combination with pembrolizumab shows improved survival rates in la/mUC

SIOG 2024: Updates in radiation oncology

SIOG 2024: Updates in medical oncology

Prophylactic tocilizumab prior to infusion of anti-CD19 CAR-T ce may reduce toxicity in older ly...

Clinical and pathologic features of elderly breast cancer patients in Tunisia

Assessment and management of toxic effects of cancer therapy in elderly patients in Tunisia

Robotic surgery for older patients with colorectal cancer shows positive outcomes

ctDNA may have a prognostic role in stage III colon cancer treated with celecoxib

The addition of trastuzumab to chemotherapy does not provide significant survival benefit in HER...

Low-dose aspirin can reduce recurrence rates in colorectal cancer patients with PI3K pathway alt...

Nivolumab plus ipilimumab shows superior efficacy in metastatic colorectal compared to nivolumab...

Everolimus plus lanreotide might be a new standard treatment in the first-line setting for grade...

A blood-based test may provide a convenient and effective option for CRC screening in the averag...

Association between risk-reducing surgeries and survival in young BRCA carriers with breast cancer

Postmastectomy radiotherapy in 'intermediate-risk' breast cancer does not impact overall survival

HER3-DXd demonstrates similar efficacy compared to multi-agent chemotherapy in high-risk HR-posi...

Olaparib after chemotherapy continues to meaningfully improveme efficacy in gBRCApv and high-ris...

Immediate breast surgery versus deferral of surgery in women aged 70+ years with operable breast...

Patients with early-stage, HR+/HER2-negative BC may benefit from adjuvant T-AC therapy more than...

Oncologists' perspectives and practices on minimal residual disease testing in multiple myeloma

Optimising immunoglobulin dosing can enhance patient outcomes in multiple myeloma

The need for improved healthcare infrastructure to enhance outcomes for ENKTL in LATAM